BCE Inc. is a communications service provider and is the holding company for Bell Canada. The company provides local and long-distance phone services. Bell Canada operates the company's wireline and wireless businesses, Bell Media as well as the satellite TV operation, known as ExpressVu. The company provides wireless service, data communications, telephone, high-speed Internet, direct-to-home satellite television and Voice over Internet Protocol services. Bell Canada also offers integrated information and communications technology services to businesses and governments and is the virtual chief information officer to small and medium businesses. BCE reports operating results in three segments - Bell Wireline, Bell Wireless and Bell Media. Bell Wireline - Provides telephone, data, video and other communications services. Bell Wireless Offers wireless voice and data communications products and services. Bell Media Offers a package of mobile content featuring the news, entertainment and sports programming....
+See More2019-10-21 10:35:00 Monday ET
American state attorneys general begin bipartisan antitrust investigations into the market power and corporate behavior of central tech titans such as Apple
2023-09-21 09:26:00 Thursday ET
Jordi Gali delves into the science of the New Keynesian monetary policy framework with economic output and inflation stabilization. Jordi Gali (2015)
2023-01-03 09:34:00 Tuesday ET
USPTO fintech patent protection and accreditation As of early-January 2023, the U.S. Patent and Trademark Office (USPTO) has approved
2023-10-07 10:24:00 Saturday ET
Thomas Philippon draws attention to greater antitrust scrutiny in light of the rise of market power and its economic ripple effects. Thomas Philippon (20
2019-06-27 10:39:00 Thursday ET
Berkeley tax economists Gabriel Zucman and Emmanuel Saez find fresh insights into wealth inequality in America. Their latest estimates show that the top 0.1
2025-10-31 12:26:00 Friday ET
With respect to wider weight loss treatment and obesity treatment, the global market for GLP-1 medications now grows substantially to benefit more than 1 bi